Detalles de la búsqueda
1.
Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
J Clin Oncol
; 39(22): 2443-2451, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33844595
2.
Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Target Oncol
; 15(6): 733-741, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33090333
Resultados
1 -
2
de 2
1
Próxima >
>>